Home Healthcare Biotechnology Isothermal Nucleic Acid Amplification Technology Market

Isothermal Nucleic Acid Amplification Technology Market Size, Share & Trends Analysis Report By Product (Instruments, Reagent), By Technology (Transcription Mediated Amplification, Loop-Mediated Isothermal Amplification, Strand Displacement Amplification, Helicase-Dependent Amplification, Nucleic Acid Sequence-Based Amplification, Others), By Application (Blood Screening, Infectious Disease Diagnostics, Cancer, Others), By End Use (Hospitals, Central & Reference Labs, Others), By Region (North America, Europe, APAC, Middle East and Africa, LATAM), Forecasts, 2026-2034

Last Updated: December 23, 2025 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Isothermal Nucleic Acid Amplification Technology Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Instruments
    2. Reagent
  2. Isothermal Nucleic Acid Amplification Technology Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Transcription Mediated Amplification (TMA)
    2. Loop-mediated isothermal amplification (LAMP)
    3. Strand Displacement Amplification (SDA)
    4. Helicase-dependent Amplification (HDA)
    5. Nucleic Acid Sequence-based Amplification (NASBA)
    6. Nicking Enzyme Amplification Reaction (NEAR)
    7. Single Primer Isothermal Amplification (SPIA)
    8. Others
  3. Isothermal Nucleic Acid Amplification Technology Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Blood screening
    2. Infectious disease diagnostics
    3. Cancer
    4. Others
  4. Isothermal Nucleic Acid Amplification Technology Market, By End-use 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Central and reference labs
    3. Other
  5. Regional Isothermal Nucleic Acid Amplification Technology Market
    1. North America
      1. North America Isothermal Nucleic Acid Amplification Technology Market By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagent
      2. North America Isothermal Nucleic Acid Amplification Technology Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Transcription Mediated Amplification (TMA)
        2. Loop-mediated isothermal amplification (LAMP)
        3. Strand Displacement Amplification (SDA)
        4. Helicase-dependent Amplification (HDA)
        5. Nucleic Acid Sequence-based Amplification (NASBA)
        6. Nicking Enzyme Amplification Reaction (NEAR)
        7. Single Primer Isothermal Amplification (SPIA)
        8. Others
      3. North America Isothermal Nucleic Acid Amplification Technology Market By Application 2022-2034 (USD MILLION/ Units)
        1. Blood screening
        2. Infectious disease diagnostics
        3. Cancer
        4. Others
      4. North America Isothermal Nucleic Acid Amplification Technology Market By End-use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Central and reference labs
        3. Other
      5. U.S.
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      6. Canada
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
    2. Europe
      1. Europe Isothermal Nucleic Acid Amplification Technology Market By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagent
      2. Europe Isothermal Nucleic Acid Amplification Technology Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Transcription Mediated Amplification (TMA)
        2. Loop-mediated isothermal amplification (LAMP)
        3. Strand Displacement Amplification (SDA)
        4. Helicase-dependent Amplification (HDA)
        5. Nucleic Acid Sequence-based Amplification (NASBA)
        6. Nicking Enzyme Amplification Reaction (NEAR)
        7. Single Primer Isothermal Amplification (SPIA)
        8. Others
      3. Europe Isothermal Nucleic Acid Amplification Technology Market By Application 2022-2034 (USD MILLION/ Units)
        1. Blood screening
        2. Infectious disease diagnostics
        3. Cancer
        4. Others
      4. Europe Isothermal Nucleic Acid Amplification Technology Market By End-use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Central and reference labs
        3. Other
      5. U.K.
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      6. Germany
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      7. France
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      8. Spain
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      9. Italy
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      10. Russia
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      11. Nordic
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      12. Benelux
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      13. Rest of Europe
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
    3. APAC
      1. APAC Isothermal Nucleic Acid Amplification Technology Market By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagent
      2. APAC Isothermal Nucleic Acid Amplification Technology Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Transcription Mediated Amplification (TMA)
        2. Loop-mediated isothermal amplification (LAMP)
        3. Strand Displacement Amplification (SDA)
        4. Helicase-dependent Amplification (HDA)
        5. Nucleic Acid Sequence-based Amplification (NASBA)
        6. Nicking Enzyme Amplification Reaction (NEAR)
        7. Single Primer Isothermal Amplification (SPIA)
        8. Others
      3. APAC Isothermal Nucleic Acid Amplification Technology Market By Application 2022-2034 (USD MILLION/ Units)
        1. Blood screening
        2. Infectious disease diagnostics
        3. Cancer
        4. Others
      4. APAC Isothermal Nucleic Acid Amplification Technology Market By End-use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Central and reference labs
        3. Other
      5. China
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      6. Korea
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      7. Japan
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      8. India
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      9. Australia
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      10. Taiwan
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      11. South East Asia
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      12. Rest of Asia-Pacific
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
    4. Middle East and Africa
      1. Middle East and Africa Isothermal Nucleic Acid Amplification Technology Market By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagent
      2. Middle East and Africa Isothermal Nucleic Acid Amplification Technology Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Transcription Mediated Amplification (TMA)
        2. Loop-mediated isothermal amplification (LAMP)
        3. Strand Displacement Amplification (SDA)
        4. Helicase-dependent Amplification (HDA)
        5. Nucleic Acid Sequence-based Amplification (NASBA)
        6. Nicking Enzyme Amplification Reaction (NEAR)
        7. Single Primer Isothermal Amplification (SPIA)
        8. Others
      3. Middle East and Africa Isothermal Nucleic Acid Amplification Technology Market By Application 2022-2034 (USD MILLION/ Units)
        1. Blood screening
        2. Infectious disease diagnostics
        3. Cancer
        4. Others
      4. Middle East and Africa Isothermal Nucleic Acid Amplification Technology Market By End-use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Central and reference labs
        3. Other
      5. UAE
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      6. Turkey
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      7. Saudi Arabia
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      8. South Africa
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      9. Egypt
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      10. Nigeria
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      11. Rest of MEA
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
    5. LATAM
      1. LATAM Isothermal Nucleic Acid Amplification Technology Market By Product 2022-2034 (USD MILLION/ Units)
        1. Instruments
        2. Reagent
      2. LATAM Isothermal Nucleic Acid Amplification Technology Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Transcription Mediated Amplification (TMA)
        2. Loop-mediated isothermal amplification (LAMP)
        3. Strand Displacement Amplification (SDA)
        4. Helicase-dependent Amplification (HDA)
        5. Nucleic Acid Sequence-based Amplification (NASBA)
        6. Nicking Enzyme Amplification Reaction (NEAR)
        7. Single Primer Isothermal Amplification (SPIA)
        8. Others
      3. LATAM Isothermal Nucleic Acid Amplification Technology Market By Application 2022-2034 (USD MILLION/ Units)
        1. Blood screening
        2. Infectious disease diagnostics
        3. Cancer
        4. Others
      4. LATAM Isothermal Nucleic Acid Amplification Technology Market By End-use 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Central and reference labs
        3. Other
      5. Brazil
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      6. Mexico
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      7. Argentina
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      8. Chile
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      9. Colombia
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
      10. Rest of LATAM
        1. Instruments
        2. Reagent
        3. Transcription Mediated Amplification (TMA)
        4. Loop-mediated isothermal amplification (LAMP)
        5. Strand Displacement Amplification (SDA)
        6. Helicase-dependent Amplification (HDA)
        7. Nucleic Acid Sequence-based Amplification (NASBA)
        8. Nicking Enzyme Amplification Reaction (NEAR)
        9. Single Primer Isothermal Amplification (SPIA)
        10. Others
        11. Blood screening
        12. Infectious disease diagnostics
        13. Cancer
        14. Others
        15. Hospitals
        16. Central and reference labs
        17. Other
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.